IN8bio, Inc. cash flow to debt ratio of -456.94% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

IN8bio, Inc.'s free cash flow has increased -47.59% from $-24.25M last year to $-12.71M, signaling increasing performance

IN8bio, Inc.'s debt to equity ratio is 0.12, which means that the company's assets are healthy financed, signaling financial stability.

IN8bio, Inc.'s debt has decreased relative to shareholder equity from 0.35 last year to 0.12 today, signaling strengthened financials

IN8bio, Inc. has a net cash position, so leverage is healthy.

IN8bio, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

IN8bio, Inc. has insufficient data to evaluate this check.

IN8bio, Inc.'s short-term assets of $27.88M exceed its short-term liabilities of $3.16M

IN8bio, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

IN8bio, Inc.'s return on equity of -91.18%, is lower than 15.00%, indicating bad performance

IN8bio, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

IN8bio, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

IN8bio, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

IN8bio, Inc. has negative free cash flow, indicating cash burn

IN8bio, Inc.'s yearly earnings has increased -36.13% since last year from $-30.44M to $-19.44M, signaling increasing performance

IN8bio, Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -91.74% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

IN8bio, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

IN8bio, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

IN8bio, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

IN8bio, Inc. has insufficient data to evaluate this check.

IN8bio, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

IN8bio, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

IN8bio, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

IN8bio, Inc. has insufficient data to evaluate this check.

IN8bio, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

IN8bio, Inc. has a price-to-book ratio of 1.03x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

IN8bio, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue